These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 19229704

  • 1. Formoterol and tiotropium compared with tiotropium alone for treatment of COPD.
    Tashkin DP, Pearle J, Iezzoni D, Varghese ST.
    COPD; 2009 Feb; 6(1):17-25. PubMed ID: 19229704
    [Abstract] [Full Text] [Related]

  • 2. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial.
    Tashkin DP, Littner M, Andrews CP, Tomlinson L, Rinehart M, Denis-Mize K.
    Respir Med; 2008 Apr; 102(4):479-87. PubMed ID: 18258423
    [Abstract] [Full Text] [Related]

  • 3. Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease.
    Tashkin DP, Hanania NA, McGinty J, Denis-Mize K, Chaudry I.
    Adv Ther; 2009 Nov; 26(11):1024-34. PubMed ID: 19953349
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease.
    Welte T, Miravitlles M, Hernandez P, Eriksson G, Peterson S, Polanowski T, Kessler R.
    Am J Respir Crit Care Med; 2009 Oct 15; 180(8):741-50. PubMed ID: 19644045
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial.
    Hanania NA, Boota A, Kerwin E, Tomlinson L, Denis-Mize K.
    Drugs; 2009 Jun 18; 69(9):1205-16. PubMed ID: 19537837
    [Abstract] [Full Text] [Related]

  • 8. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD.
    van Noord JA, Aumann JL, Janssens E, Verhaert J, Smeets JJ, Mueller A, Cornelissen PJ.
    Chest; 2006 Mar 18; 129(3):509-17. PubMed ID: 16537846
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bronchodilator efficacy of tiotropium-formoterol via single pressurized meter dose inhaler (pMDI) versus tiotropium alone in COPD.
    Salvi S, Brashier B, Gothi D, Karkhanis V, Madas S, Gogtay J, Joshi J.
    Pulm Pharmacol Ther; 2014 Feb 18; 27(1):90-5. PubMed ID: 23752057
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study.
    Vogelmeier C, Kardos P, Harari S, Gans SJ, Stenglein S, Thirlwell J.
    Respir Med; 2008 Nov 18; 102(11):1511-20. PubMed ID: 18804362
    [Abstract] [Full Text] [Related]

  • 14. Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD.
    Tashkin DP, Donohue JF, Mahler DA, Huang H, Goodwin E, Schaefer K, Hanrahan JP, Andrews WT.
    Respir Med; 2009 Apr 18; 103(4):516-24. PubMed ID: 19208459
    [Abstract] [Full Text] [Related]

  • 15. Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD.
    Partridge MR, Schuermann W, Beckman O, Persson T, Polanowski T.
    Ther Adv Respir Dis; 2009 Aug 18; 3(4):1-11. PubMed ID: 19734176
    [Abstract] [Full Text] [Related]

  • 16. Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD.
    van Noord JA, Aumann JL, Janssens E, Smeets JJ, Verhaert J, Disse B, Mueller A, Cornelissen PJ.
    Eur Respir J; 2005 Aug 18; 26(2):214-22. PubMed ID: 16055868
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
    Bölükbas S, Eberlein M, Eckhoff J, Schirren J.
    Eur J Cardiothorac Surg; 2011 Jun 18; 39(6):995-1000. PubMed ID: 20970351
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD.
    Hanania NA, Crater GD, Morris AN, Emmett AH, O'Dell DM, Niewoehner DE.
    Respir Med; 2012 Jan 18; 106(1):91-101. PubMed ID: 22040533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.